Literature DB >> 21160601

Drug eluting balloons for the treatment of coronary artery disease: What can we expect?

Alexander Joost1, Volkhard Kurowski, Peter W Radke.   

Abstract

Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patients with diffuse in-stent restenosis (ISR). At present, however, a number of questions regarding long-term efficacy and safety remain, specifically in indications other than diffuse ISR. The results of the evaluation of different substances, balloon systems and clinical indications will determine the long-term success of DEBs.

Entities:  

Keywords:  Coronary artery disease; Coronary balloon angioplasty; Drug delivery systems; Vascular graft restenosis

Year:  2010        PMID： 21160601      PMCID： PMC2999067          DOI： 10.4330/wjc.v2.i9.257

Source DB:  PubMed          Journal:  World J Cardiol


  16 in total

1.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

2.  Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model.

Authors:  Bodo Cremers; Melanie Biedermann; Dirk Mahnkopf; Michael Böhm; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2009-03-12       Impact factor: 5.460

3.  Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis.

Authors:  Janine Pöss; Claudius Jacobshagen; Christian Ukena; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2010-05-25       Impact factor: 5.460

4.  Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.

Authors:  Martin Unverdorben; Franz X Kleber; Hubertus Heuer; Hans-Reiner Figulla; Christian Vallbracht; Matthias Leschke; Bodo Cremers; Stefan Hardt; Michael Buerke; Hanns Ackermann; Michael Boxberger; Ralf Degenhardt; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2010-01-06       Impact factor: 5.460

5.  Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

Authors:  D I Axel; W Kunert; C Göggelmann; M Oberhoff; C Herdeg; A Küttner; D H Wild; B R Brehm; R Riessen; G Köveker; K R Karsch
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

6.  Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

Authors:  David R Holmes; Paul Teirstein; Lowell Satler; Michael Sketch; James O'Malley; Jeffery J Popma; Richard E Kuntz; Peter J Fitzgerald; Hong Wang; Eileen Caramanica; Sidney A Cohen
Journal:  JAMA       Date:  2006-03-12       Impact factor: 56.272

7.  Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.

Authors:  James C Fanggiday; Pieter R Stella; Siyrous Hoseyni Guyomi; Pieter A Doevendans
Journal:  Catheter Cardiovasc Interv       Date:  2008-04-01       Impact factor: 2.692

8.  Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.

Authors:  Bruno Scheller; Ulrich Speck; Claudia Abramjuk; Ulrich Bernhardt; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

9.  Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.

Authors:  Michael Werk; Soenke Langner; Bianka Reinkensmeier; Hans-Frank Boettcher; Gunnar Tepe; Ulrich Dietz; Norbert Hosten; Bernd Hamm; Ulrich Speck; Jens Ricke
Journal:  Circulation       Date:  2008-09-08       Impact factor: 29.690

Review 10.  Paclitaxel-eluting balloon: from bench to bed.

Authors:  Axel De Labriolle; Rajbabu Pakala; Laurent Bonello; Gilles Lemesle; Mickey Scheinowitz; Ron Waksman
Journal:  Catheter Cardiovasc Interv       Date:  2009-04-01       Impact factor: 2.692
View more
  2 in total

Review 1.  Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview.

Authors:  C D Ramakrishna; Bhargav A Dave; Pankaj S Kothavade; Kajal J Joshi; Ashok S Thakkar
Journal:  J Clin Diagn Res       Date:  2017-06-01

2.  Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation.

Authors:  Tobias Kammerer; Andres Beiras-Fernandez; Markus Rehm; Manfred Stangl; Markus Guba; Christian Kupatt-Jeremias; Florian Weis
Journal:  BMC Cardiovasc Disord       Date:  2014-09-01       Impact factor: 2.298
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.